BillionToOne, Inc.(BLLN)

Medical - Diagnostics & Research · Menlo Park, CA

$110.37+1.31 (+1.20%)

Delayed quote: Oct 6, 2026, 9:35 AM EDT

Price/FCF Ratio: 153.03

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the Price/FCF ratio high or low?

The Price/FCF ratio of 153.03 is 21% below its estimated 1-year average of 194.41, near the low end of its estimated 1-year range (136.16–283.14).

As of 2026-10-06T13:35:47.840Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:35:47.840Z.

Quote observation: 2026-10-06T13:35:03.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 5,076,521,679
TTM free cash flow · period ending 2026-06-30: 33,174,000

FMP input reference: 38b5431cb1e3da682f5ebe5fe36c67887aeb28768e172b1d79306996b6f580d0

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Price/FCF Ratio

BLLN Price/FCF Ratio Chart

153.03

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.

BLLN Price/FCF Ratio Metrics

PRICE/FCF RATIO

153.03

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

21.60

median of 161 covered companies

CURRENT VS SECTOR MEDIAN

+608.47%

vs the sector median at left

BLLN Competitors' Price/FCF Ratio

BLLN

BillionToOne, Inc.

Current

Market Cap

$5.08B

Price/FCF Ratio

153.03

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ERAS

Erasca, Inc.

vs BLLN

Market Cap

$5.11B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MMSI

Merit Medical Systems, Inc.

vs BLLN

Market Cap

$5.29B

Price/FCF Ratio

25.98

TTM Avg

26.02

3Y Avg

39.55

5Y Avg

43.37

DNTH

Dianthus Therapeutics, Inc.

vs BLLN

Market Cap

$4.93B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRRK

Scholar Rock Holding Corporation

vs BLLN

Market Cap

$5.23B

Price/FCF Ratio

N/A

TTM Avg

35.18

3Y Avg

35.18

5Y Avg

35.18

ADPT

Adaptive Biotechnologies Corporation

vs BLLN

Market Cap

$4.89B

Price/FCF Ratio

N/A

TTM Avg

18.04

3Y Avg

18.04

5Y Avg

18.04

COGT

Cogent Biosciences, Inc.

vs BLLN

Market Cap

$5.28B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DFTX

Definium Therapeutics, Inc.

vs BLLN

Market Cap

$4.77B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DOCS

Doximity, Inc.

vs BLLN

Market Cap

$5.40B

Price/FCF Ratio

18.03

TTM Avg

21.47

3Y Avg

35.28

5Y Avg

47.18

LFST

LifeStance Health Group, Inc.

vs BLLN

Market Cap

$4.78B

Price/FCF Ratio

27.48

TTM Avg

23.99

3Y Avg

32.53

5Y Avg

32.53

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
BillionToOne, Inc. (BLLN)	$5.08B	153.03	N/A	N/A	N/A
Erasca, Inc. (ERAS)vs ›	$5.11B	N/A	N/A	N/A	N/A
Merit Medical Systems, Inc. (MMSI)vs ›	$5.29B	25.98	26.02	39.55	43.37
Dianthus Therapeutics, Inc. (DNTH)vs ›	$4.93B	N/A	N/A	N/A	N/A
Scholar Rock Holding Corporation (SRRK)vs ›	$5.23B	N/A	35.18	35.18	35.18
Adaptive Biotechnologies Corporation (ADPT)vs ›	$4.89B	N/A	18.04	18.04	18.04
Cogent Biosciences, Inc. (COGT)vs ›	$5.28B	N/A	N/A	N/A	N/A
Definium Therapeutics, Inc. (DFTX)vs ›	$4.77B	N/A	N/A	N/A	N/A
Doximity, Inc. (DOCS)vs ›	$5.40B	18.03	21.47	35.28	47.18
LifeStance Health Group, Inc. (LFST)vs ›	$4.78B	27.48	23.99	32.53	32.53

Free Cash Flow Valuation

P/FCF Ratio

153.0

FCF Yield

0.65%

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio FAQ

What is the Price/FCF ratio for BillionToOne, Inc. (BLLN)?: The Price/FCF ratio for BLLN stock is 153.03.
Is BillionToOne, Inc.'s Price/FCF ratio high or low?: The Price/FCF ratio of 153.03 is 21% below its estimated 1-year average of 194.41, near the low end of its estimated 1-year range (136.16–283.14).

BLLN Price/FCF Ratio History

DATE	PRICE/FCF RATIO
2026-10-05	179.02
2026-10-02	173.84
2026-10-01	173.61
2026-09-30	174.72
2026-09-29	193.99
2026-09-28	199.80
2026-09-25	202.04
2026-09-24	205.02
2026-09-23	187.82
2026-09-22	190.53
2026-09-21	170.49
2026-09-18	173.87
2026-09-17	181.67
2026-09-16	170.08
2026-09-15	171.16
2026-09-14	165.50
2026-09-11	162.13
2026-09-10	161.71
2026-09-09	162.77
2026-09-08	162.61
2026-09-04	163.15
2026-09-03	163.33
2026-09-02	157.83
2026-09-01	151.54
2026-08-31	148.84
2026-08-28	153.05
2026-08-27	156.19
2026-08-26	157.95
2026-08-25	164.28
2026-08-24	158.80
2026-08-21	155.99
2026-08-20	156.39
2026-08-19	150.48
2026-08-18	144.44
2026-08-17	154.15
2026-08-14	153.20
2026-08-13	154.37
2026-08-12	159.97
2026-08-11	160.77
2026-08-10	161.94
2026-08-07	153.30
2026-08-06	150.44
2026-08-05	283.14
2026-08-04	268.57
2026-08-03	259.26
2026-07-31	261.68
2026-07-30	263.55
2026-07-29	250.20
2026-07-28	252.31
2026-07-27	241.63
2026-07-24	238.04
2026-07-23	243.44
2026-07-22	244.01
2026-07-21	250.22
2026-07-20	236.26
2026-07-17	246.03
2026-07-16	242.00
2026-07-15	245.21
2026-07-14	235.76
2026-07-13	232.70
2026-07-10	239.34
2026-07-09	241.61
2026-07-08	227.69
2026-07-07	222.86
2026-07-06	232.98
2026-07-02	227.22
2026-07-01	230.96
2026-06-30	226.52
2026-06-29	227.32
2026-06-26	223.11
2026-06-25	211.91
2026-06-24	203.41
2026-06-23	196.88
2026-06-22	190.16
2026-06-18	198.52
2026-06-17	187.63
2026-06-16	190.12
2026-06-15	196.26
2026-06-12	190.91
2026-06-11	188.14
2026-06-10	187.40
2026-06-09	193.31
2026-06-08	178.28
2026-06-05	183.50
2026-06-04	197.47
2026-06-03	185.70
2026-06-02	177.94
2026-06-01	172.03
2026-05-29	186.89
2026-05-28	184.65
2026-05-27	171.85
2026-05-26	159.50
2026-05-22	162.22
2026-05-21	162.65
2026-05-20	157.42
2026-05-19	155.36
2026-05-18	162.59
2026-05-15	156.01
2026-05-14	166.03
2026-05-13	171.03
2026-05-12	177.91
2026-05-11	200.02
2026-05-08	175.51
2026-05-07	175.40
2026-05-06	153.68
2026-05-05	150.85
2026-05-04	136.16
2026-05-01	146.30
2026-04-30	141.69
2026-04-29	139.16
2026-04-28	147.70
2026-04-27	154.36
2026-04-24	159.99
2026-04-23	158.46
2026-04-22	163.95
2026-04-21	168.03
2026-04-20	164.20
2026-04-17	149.96
2026-04-16	148.81
2026-04-15	152.19
2026-04-14	156.31
2026-04-13	148.59
2026-04-10	153.17
2026-04-09	155.76
2026-04-08	173.66
2026-04-07	166.99
2026-04-06	161.42
2026-04-02	149.83
2026-04-01	156.63
2026-03-31	207.73
2026-03-30	184.50
2026-03-27	183.02
2026-03-26	188.00
2026-03-25	202.63
2026-03-24	194.95
2026-03-23	209.45
2026-03-20	200.00
2026-03-19	194.73
2026-03-18	187.55
2026-03-17	183.58
2026-03-16	187.73
2026-03-13	181.87
2026-03-12	168.50
2026-03-11	177.26
2026-03-10	184.73
2026-03-09	189.76
2026-03-06	193.45
2026-03-05	189.92
2026-03-04	212.71
2026-03-03	218.79
2026-03-02	206.97
2026-02-27	200.87
2026-02-26	187.92
2026-02-25	184.23
2026-02-24	185.79
2026-02-23	189.73
2026-02-20	224.79
2026-02-19	237.94
2026-02-18	235.84
2026-02-17	245.21
2026-02-13	233.18
2026-02-12	236.02
2026-02-11	225.63
2026-02-10	241.94
2026-02-09	243.18
2026-02-06	238.44
2026-02-05	224.08
2026-02-04	219.76
2026-02-03	217.60
2026-02-02	219.89
2026-01-30	217.13
2026-01-29	213.71
2026-01-28	226.44
2026-01-27	225.16
2026-01-26	226.79
2026-01-23	230.44
2026-01-22	238.31
2026-01-21	221.34
2026-01-20	226.18
2026-01-16	233.50
2026-01-15	249.26
2026-01-14	248.34
2026-01-13	254.87
2026-01-12	260.92
2026-01-09	226.16
2026-01-08	230.50
2026-01-07	235.37
2026-01-06	249.68
2026-01-05	250.00
2026-01-02	234.97

About BillionToOne, Inc.

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Menlo Park, CA

713 employees

www.billiontoone.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Oguzhan Atay

View full financials

BLLN Price/FCF Ratio Metrics

PRICE/FCF RATIO

153.03

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

21.60

median of 161 covered companies

CURRENT VS SECTOR MEDIAN

+608.47%

vs the sector median at left

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

BillionToOne, Inc. (BLLN)

$5.08B

153.03

N/A

Erasca, Inc. (ERAS)vs ›

$5.11B

N/A

Merit Medical Systems, Inc. (MMSI)vs ›

$5.29B

25.98

26.02

39.55

43.37

Dianthus Therapeutics, Inc. (DNTH)vs ›

$4.93B

N/A

Scholar Rock Holding Corporation (SRRK)vs ›

$5.23B

N/A

35.18

Adaptive Biotechnologies Corporation (ADPT)vs ›

$4.89B

N/A

18.04

Cogent Biosciences, Inc. (COGT)vs ›

$5.28B

N/A

Definium Therapeutics, Inc. (DFTX)vs ›

$4.77B

N/A

Doximity, Inc. (DOCS)vs ›

$5.40B

18.03

21.47

35.28

47.18

LifeStance Health Group, Inc. (LFST)vs ›

$4.78B

27.48

23.99

32.53

Price/FCF Ratio FAQ

What is the Price/FCF ratio for BillionToOne, Inc. (BLLN)?

The Price/FCF ratio for BLLN stock is 153.03.

Is BillionToOne, Inc.'s Price/FCF ratio high or low?

The Price/FCF ratio of 153.03 is 21% below its estimated 1-year average of 194.41, near the low end of its estimated 1-year range (136.16–283.14).

DATE

PRICE/FCF RATIO

2026-10-05

179.02

2026-10-02

173.84

2026-10-01

173.61

2026-09-30

174.72

2026-09-29

193.99

2026-09-28

199.80

2026-09-25

202.04

2026-09-24

205.02

2026-09-23

187.82

2026-09-22

190.53

2026-09-21

170.49

2026-09-18

173.87

2026-09-17

181.67

2026-09-16

170.08

2026-09-15

171.16

2026-09-14

165.50

2026-09-11

162.13

2026-09-10

161.71

2026-09-09

162.77

2026-09-08

162.61

2026-09-04

163.15

2026-09-03

163.33

2026-09-02

157.83

2026-09-01

151.54

2026-08-31

148.84

2026-08-28

153.05

2026-08-27

156.19

2026-08-26

157.95

2026-08-25

164.28

2026-08-24

158.80

2026-08-21

155.99

2026-08-20

156.39

2026-08-19

150.48

2026-08-18

144.44

2026-08-17

154.15

2026-08-14

153.20

2026-08-13

154.37

2026-08-12

159.97

2026-08-11

160.77

2026-08-10

161.94

2026-08-07

153.30

2026-08-06

150.44

2026-08-05

283.14

2026-08-04

268.57

2026-08-03

259.26

2026-07-31

261.68

2026-07-30

263.55

2026-07-29

250.20

2026-07-28

252.31

2026-07-27

241.63

2026-07-24

238.04

2026-07-23

243.44

2026-07-22

244.01

2026-07-21

250.22

2026-07-20

236.26

2026-07-17

246.03

2026-07-16

242.00

2026-07-15

245.21

2026-07-14

235.76

2026-07-13

232.70

2026-07-10

239.34

2026-07-09

241.61

2026-07-08

227.69

2026-07-07

222.86

2026-07-06

232.98

2026-07-02

227.22

2026-07-01

230.96

2026-06-30

226.52

2026-06-29

227.32

2026-06-26

223.11

2026-06-25

211.91

2026-06-24

203.41

2026-06-23

196.88

2026-06-22

190.16

2026-06-18

198.52

2026-06-17

187.63

2026-06-16

190.12

2026-06-15

196.26

2026-06-12

190.91

2026-06-11

188.14

2026-06-10

187.40

2026-06-09

193.31

2026-06-08

178.28

2026-06-05

183.50

2026-06-04

197.47

2026-06-03

185.70

2026-06-02

177.94

2026-06-01

172.03

2026-05-29

186.89

2026-05-28

184.65

2026-05-27

171.85

2026-05-26

159.50

2026-05-22

162.22

2026-05-21

162.65

2026-05-20

157.42

2026-05-19

155.36

2026-05-18

162.59

2026-05-15

156.01

2026-05-14

166.03

2026-05-13

171.03

2026-05-12

177.91

2026-05-11

200.02

2026-05-08

175.51

2026-05-07

175.40

2026-05-06

153.68

2026-05-05

150.85

2026-05-04

136.16

2026-05-01

146.30

2026-04-30

141.69

2026-04-29

139.16

2026-04-28

147.70

2026-04-27

154.36

2026-04-24

159.99

2026-04-23

158.46

2026-04-22

163.95

2026-04-21

168.03

2026-04-20

164.20

2026-04-17

149.96

2026-04-16

148.81

2026-04-15

152.19

2026-04-14

156.31

2026-04-13

148.59

2026-04-10

153.17

2026-04-09

155.76

2026-04-08

173.66

2026-04-07

166.99

2026-04-06

161.42

2026-04-02

149.83

2026-04-01

156.63

2026-03-31

207.73

2026-03-30

184.50

2026-03-27

183.02

2026-03-26

188.00

2026-03-25

202.63

2026-03-24

194.95

2026-03-23

209.45

2026-03-20

200.00

2026-03-19

194.73

2026-03-18

187.55

2026-03-17

183.58

2026-03-16

187.73

2026-03-13

181.87

2026-03-12

168.50

2026-03-11

177.26

2026-03-10

184.73

2026-03-09

189.76

2026-03-06

193.45

2026-03-05

189.92

2026-03-04

212.71

2026-03-03

218.79

2026-03-02

206.97

2026-02-27

200.87

2026-02-26

187.92

2026-02-25

184.23

2026-02-24

185.79

2026-02-23

189.73

2026-02-20

224.79

2026-02-19

237.94

2026-02-18

235.84

2026-02-17

245.21

2026-02-13

233.18

2026-02-12

236.02

2026-02-11

225.63

2026-02-10

241.94

2026-02-09

243.18

2026-02-06

238.44

2026-02-05

224.08

2026-02-04

219.76

2026-02-03

217.60

2026-02-02

219.89

2026-01-30

217.13

2026-01-29

213.71

2026-01-28

226.44

2026-01-27

225.16

2026-01-26

226.79

2026-01-23

230.44

2026-01-22

238.31

2026-01-21

221.34

2026-01-20

226.18

2026-01-16

233.50

2026-01-15

249.26

2026-01-14

248.34

2026-01-13

254.87

2026-01-12

260.92

2026-01-09

226.16

2026-01-08

230.50

2026-01-07

235.37

2026-01-06

249.68

2026-01-05

250.00

2026-01-02

234.97

Price/FCF Ratio: 153.03

BLLN Price/FCF Ratio Chart

BLLN Price/FCF Ratio Metrics

BLLN Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Price/FCF Ratio FAQ

BLLN Price/FCF Ratio History

Related Metrics

Price/FCF Ratio: 153.03

BLLN Price/FCF Ratio Chart

BLLN Price/FCF Ratio Metrics

BLLN Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Price/FCF Ratio FAQ

BLLN Price/FCF Ratio History

Related Metrics